- Entourage (ENTG) has launched Syndicate, a direct-to-patient medical cannabis marketplace
- Syndicate will serve patients without insurance at a competitive price point
- Patients from Ontario are now being accepted, with more provinces to follow
- Entourage Health produces and distributes cannabis products for both the medical and adult-use markets
- Entourage (ENTG) opened unchanged, trading at $0.035 per share
Entourage (ENTG) has launched Syndicate, a direct-to-patient medical cannabis marketplace.
Syndicate showcases over 50 premium craft cannabis products sourced both in-house and from third-party micro-cultivators and producers. Brands on offer include Greenseal Cannabis, Sitka Micro, Premium 5 and QWest Cannabis.
The new marketplace will cater to clients without insurance at a competitive price point, supplementing Entourage’s insured benefits channel, Starseed Medicinal.
Patients in Ontario can now register for Syndicate, with more provinces to follow.
“With Syndicate, we are returning to our roots with access to medical cannabis at the heart of our purpose,” stated George Scorsis, Entourage’s CEO and Executive Chairman. “We continue to advocate for cannabis medicine to be an insured benefit, but we know the reality is that not all our clients have access, and this channel is dedicated to those patients.”
Entourage Health produces and distributes cannabis products for both the medical and adult-use markets. Its brands include Color Cannabis, Saturday Cannabis and Royal City Cannabis.
Entourage (ENTG) opened unchanged, trading at $0.035 per share.
